HARCP

HEROIN ADDICTION AND
RELATED CLINICAL PROBLEMS

The official journal of
EUROPAD - European Opiate Addiction Treatment Association
WFTOD - World Federation for the Treatment of Opioid Dependence
Editor: Icro Maremmani, MD - Pisa, Italy, EU
Associate Editors:
Thomas Clausen, MD - Oslo, Norway
Pier Paolo Pani, MD - Cagliari, Italy, EU
Marta Torrens, MD - Barcelona, Spain, EU
Statistical Editor:
Mario Miccoli, PhD - Pisa, Italy, EU

HARCP Archives

Browse by article Browse by volume    

Heroin Addiction and Related Clinical Problems: 2007, 09, 2 (pages: 11 - 16)

Buprenorphine for Dual Dependency: Cocaine, Alcohol and Opiates

Gardner T., Kosten T.

Summary: Dual-drug dependency is common in Europe and America and represents a complex management and treatment challenge. Most heroin addicts abuse stimulants or alcohol in addition to opiates. Cocaine pharmacotherapy remains a challenge, but there has been some success with Buprenorphine, Disulfiram, Modafinil and GABA agonists. A promising cocaine vaccine is also under development. Triple-dependency with alcohol or benzodiazepines is also common and can lead to serious dependence requiring detoxification. In addition to regular monitoring following alcohol detoxification, relapse prevention pharmacotherapy is essential. The following review will briefly describe concurrent-drug abuse with cocaine and opiates as well as describe current pharmacotherapies for multi-drug dependence. In addition, we will briefly discuss the implications for combining behavioral therapies with medications to improve treatment efficacy.

 

AU-CNS Associazione per lā€™Utilizzo delle Conoscenze Neuroscientifiche a fini Sociali
Association for the Application of Neuroscientific Knowledge to Social Aims
Via XX Settembre, 83 ā€“ 55045 PIETRASANTA (Lucca) - Italy
P. IVA 01681650469 ā€“ Codice Fiscale 94002580465 Reserved Area
Tel/Phone: 0584 - 790073 - Email: info@heroinaddictionrelatedclinicalproblems.org
Start of page